CME Sessions at EANM’07

EANM’07 – CME Session XIII

October 17, 2007, 10:00 – 11:30
State-of-the-art in multinodular goitre therapy

Moderator: M. Luster (Würzburg)
Co-Moderator: B. Brans (Maastricht)

S. Bonnema (Odense):
Diagnostic aspects of multinodular goitre
S. Clarke (London):
Therapeutic aspects of multinodular toxic goitre
D. Huysmans (Eindhoven):
Therapeutic aspects of multinodular non-toxic goitre

Educational objectives:

Upon completion of this course the attendee will:

  1. be able to cover the diagnostic examinations used when evaluating a symptomatic goitre.
  2. appreciate the roles of FNAC, pulmonary function testing and therapeutic threshold in relation to the indication of radioiodine therapy, especially with regard to symptoms and quality of life.
  3. know the relative indications of surgery and levothyroine (L-T4) medication in these patients.
  4. know effects and side-effects of radioiodine in the treatment of toxic and non-toxic goitre.
  5. understand different aspects of activity administration and dosimetry.
  6. review the state of affairs on adjuvant use of recombinant TSH in the treatment of non-toxic goitre.


This continuing education session is directed primarily towards physicians active in treating goitre with radioiodine, and may also be of interest to everyone else involved in the diagnosis and treatment of these patients. Radioiodine therapy of thyroid diseases is in fact an everyday practice in many institutions. The therapy of goitre is for most of us, but not all, an important part of this. By getting an overview of the current state-of-the art and recent developments, this sessions seeks to provide a foundation to participants for refining their services. Accordance with guidelines, standardized reporting, latest methodology and broadening of the indications will be covered and, if implemented, will help to increase acceptance of radioiodine therapy for this effective and prevalent indication.

Key Words:

Radionuclide therapy, therapeutic radio-isotopes, radio-iodine therapy, multinodular toxic goitre, multinodular non-toxic goitre, recombinant human TSH

This website uses cookies. Learn more